info@seagull-health.com
SeagullHealth
语言:
search
new
Indications for Enstilar
501
Article source: Seagull Pharmacy
Nov 06, 2025

Enstilar is an innovative topical fixed-dose combination preparation that integrates the dual effects of a vitamin D analog and a corticosteroid, specifically designed for the treatment of plaque psoriasis.

Indications for Enstilar

Primary Target Population

Approved by the U.S. FDA, Enstilar is indicated for the topical treatment of plaque psoriasis in patients aged 12 years and older.

Through its unique mechanism of action, this medication significantly improves the symptoms of psoriatic lesions.

Applicable Disease Type

This product specifically targets the lesional areas of plaque psoriasis. With a once-daily administration regimen, it can effectively control disease progression.

Specifications and Physical Characteristics of Enstilar

Pharmaceutical Composition

Each gram of the foam contains 50 micrograms of calcipotriene (equivalent to 52.2 micrograms of calcipotriene monohydrate) and 0.643 milligrams of betamethasone dipropionate (equivalent to 0.5 milligrams of betamethasone).

The specification is labeled as 0.005%/0.064%, representing the precise concentration ratio of the active ingredients.

Description of Physical Properties

The product is a white to off-white opalescent liquid, stored in a pressurized aluminum spray can.

When applied, it appears as a white to off-white foam, which gradually collapses as the propellant evaporates.

Excipients and Propellants

The base contains white petrolatum, polyoxypropylene stearyl ether, mineral oil, racemic α-tocopherol, and butylated hydroxytoluene. Dimethyl ether and butane are used as propellants.

Storage and Handling Instructions for Enstilar

Temperature Control Requirements

The storage temperature should be maintained between 20°C-25°C (68°F-77°F), with an allowable fluctuation range of 15°C-30°C (59°F-86°F).

Safety Precautions

The container is a high-pressure product; piercing or incineration is strictly prohibited.

Avoid exposure to high-temperature environments or storage temperatures exceeding 120°F (49°C).

Strict Prohibition of Freezing Storage

Management of Usage Period: After opening the can, any unused product should be discarded within 6 months.

Special Usage Guidelines

The can must be shaken thoroughly before use.

The can may be held in any orientation for spraying, except horizontally.

Summary of Precautions

This product is flammable. Keep it away from heat sources and open flames during use, and smoking is prohibited.

Store it in a safe place out of the reach of children.

Pay attention to the expiration date of the product; use of expired products is strictly prohibited.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Purchase Enstilar
Enstilar is a prescription medication and must be obtained in strict compliance with medical regulatory procedures. It contains calcipotriene (a vitamin D analog) and betamethasone dipropionate (a cor...
What Are the Side Effects of Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)?
Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is a fixed-dose combination preparation for the treatment of type 2 diabetes. It provides effective blood glucose control for ...
How to Use Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is a fixed-dose combination antihyperglycemic medication. It contains sitagliptin (a dipeptidyl peptidase-4 inhibitor) and met...
Indications for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is an innovative oral combination anti-diabetic formulation that integrates the dual advantages of a dipeptidyl peptidase-4 (D...
How to Use Enstilar
Enstilar is a fixed-dose combination medication for the topical treatment of plaque psoriasis, integrating the therapeutic advantages of calcipotriene (a vitamin D analog) and betamethasone dipropiona...
How to Purchase Tivozanib (Fotivda)
Tivozanib (Fotivda) is a kinase inhibitor indicated for the treatment of adult patients with recurrent or refractory advanced renal cell carcinoma (RCC) who have received two or more prior systemic th...
Precautions for Administration of Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is a fixed-dose combination antihyperglycemic formulation. It integrates the dual advantages of sitagliptin (a dipeptidyl pept...
How to Purchase Odevixibat (Bylvay)
Odevixibat (Bylvay) is an ileal bile acid transporter (IBAT) inhibitor primarily indicated for the treatment of pruritus associated with progressive familial intrahepatic cholestasis (PFIC) and Alagil...
Related Articles
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
Adverse Reactions of Sitagliptin/Metformin Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Extended-Release Tablets (Janumet XR) is a commonly used fixed-dose combination preparation for type 2 diabetes mellitus. While effectively controlling blood glucose, patients ne...
What are the Precautions for Using Sitagliptin/Metformin Extended-Release Tablets (Janumet XR)?
Sitagliptin/Metformin Extended-Release Tablets (Janumet XR) is a combination antihyperglycemic medication that plays an important role in the treatment of type 2 diabetes mellitus. To ensure medicatio...
Dosage and Administration, Recommended Dosage of Sitagliptin/Metformin Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Extended-Release Tablets (Janumet XR) is a fixed-dose combination oral antihyperglycemic medication. It combines sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, with met...
What are the Indications for Sitagliptin/Metformin Extended-Release Tablets (Janumet XR)?
Sitagliptin/Metformin Extended-Release Tablets (Janumet XR) is a novel fixed-dose combination antihyperglycemic medication. It integrates two hypoglycemic ingredients with distinct mechanisms of actio...
Where to Purchase Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is an important medication for the treatment of type 2 diabetes mellitus. Patients pay close attention to issues such as the l...
Dosage and Administration of Pemigatinib (Pemazyre) - Recommended Doses
Pemigatinib (Pemazyre) is a targeted therapy for specific genetic abnormalities, mainly indicated for the treatment of cholangiocarcinoma with FGFR2 genetic abnormalities and myeloid/lymphoid neoplasm...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved